NCT02538874View on ClinicalTrials.gov

A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 4, 2016

Study Completion Date

November 5, 2016

Conditions
Liver Fibrosis/NASH
Interventions
DRUG

BMS-986171

OTHER

Placebo

Trial Locations (2)

90630

Wcct Global, Llc, Cypress

91911

Profil Institute For Clinical Research, Inc., Chula Vista

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY